نتائج البحث - "Herold, J."

المصدر: 2019, ' Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades ', Alimentary Pharmacology and Therapeutics, vol. 49, no. 3, pp. 285-295 . https://doi.org/10.1111/apt.15060Test
Alimentary Pharmacology & Therapeutics, 49(3), 285-295. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6869b90f8037963bc1a38a5452454cdTest
https://doi.org/10.1111/apt.15060Test

5

Safe use of proton pump inhibitors in patients with cirrhosis

المؤلفون: Katja Taxis, Margriet Bouma, S. Froukje Harkes-Idzinga, David M. Burger, Rianne A. Weersink, Sandra A.W. van Putten, Sander D. Borgsteede, Herold J. Metselaar, Nicole G. M. Hunfeld, Margje H. Monster-Simons, Joost P.H. Drenth

المصدر: British Journal of Clinical Pharmacology. 84:1806-1820

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8e64fc5fd929a833de1b0093aec08bbdTest
https://doi.org/10.1111/bcp.13615Test

6

Editorial: liver transplantation for primary biliary cholangitis-the need for timely and more effective treatments. Authors' reply

المؤلفون: Maren H. Harms, Bettina E. Hansen, Henk R. van Buuren, Herold J. Metselaar

المساهمون: Gastroenterology & Hepatology

المصدر: Alimentary Pharmacology & Therapeutics, 49(4), 473-474. Wiley-Blackwell Publishing Ltd

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c1cc049e14a2e275061fe94a56411bTest
https://pubmed.ncbi.nlm.nih.gov/30689256Test

7

Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid

المؤلفون: Petra E. de Ruiter, Robert J. de Knegt, Herold J. Metselaar, Jan Nm Ijzermans, Yashna Gadjradj, Luc J. W. van der Laan

المساهمون: Surgery, Gastroenterology & Hepatology

المصدر: World Journal of Transplantation
World Journal of Transplantation, 8(5), 156-166. Baishideng Publishing Group

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4704c6787f8e2f37ef5cc6a65621304aTest
https://pubmed.ncbi.nlm.nih.gov/30211024Test

8

Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study

المؤلفون: Lutz, Fischer, Faouzi, Saliba, Gernot M, Kaiser, Luciano, De Carlis, Herold J, Metselaar, Paolo, De Simone, Christophe, Duvoux, Frederik, Nevens, John J, Fung, Gaohong, Dong, Barbara, Rauer, Guido, Junge, K, Watt

المساهمون: Gastroenterology & Hepatology, Fischer, L, Saliba, F, Kaiser, G, De Carlis, L, Metselaar, H, De Simone, P, Duvoux, C, Nevens, F, Fung, J, Dong, G, Rauer, B, Junge, G

المصدر: Transplantation, 99(7), 1455-1462. Lippincott Williams & Wilkins

مصطلحات موضوعية: Graft Rejection, Male, Time Factors, medicine.medical_treatment, Medizin, Liver transplantation, Kidney, law.invention, Immunosuppressive Agent, Randomized controlled trial, law, Risk Factors, Prospective Studies, Prospective cohort study, Graft Survival, Middle Aged, Immunosuppression, Europe, Everolimu, Treatment Outcome, Tacrolimu, Drug Therapy, Combination, Female, Immunosuppressive Agents, medicine.drug, Human, Glomerular Filtration Rate, Adult, medicine.medical_specialty, Randomization, Time Factor, Urology, chemical and pharmacologic phenomena, Drug Administration Schedule, Tacrolimus, medicine, Humans, Everolimus, Adverse effect, Aged, Transplantation, business.industry, Risk Factor, Surgery, Calcineurin, Prospective Studie, business